首页 > 市场调查报告书 > 医疗设备

神经復健设备市场规模、份额和成长分析（按类型、应用、最终用户和地区划分）—2026-2033年产业预测

市场调查报告书

商品编码

1898669

神经復健设备市场规模、份额和成长分析（按类型、应用、最终用户和地区划分）—2026-2033年产业预测

Neurorehabilitation Devices Market Size, Share, and Growth Analysis, By Type (Neuro-Robotic Devices, Non-Invasive Stimulators), By Application (Brain Stroke, Parkinson's Disease), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，神经復健设备市场规模将达到 17.3 亿美元，到 2025 年将达到 18.8 亿美元，到 2033 年将达到 35.8 亿美元，预测期（2026-2033 年）的复合年增长率为 8.4%。

神经復健设备市场正随着人们对有效治疗方法神经系统疾病（例如中风、多发性硬化症和帕金森氏症）的需求不断增长而不断发展，而这种需求的增长又受到人口老龄化和生活方式改变导致的患病率上升的推动。这种需求凸显了对创新解决方案的迫切需求，这些解决方案能够促进復原、改善功能能力，并提供个人化治疗，帮助患者重获独立生活能力。市场面临许多挑战，例如需要持续研究以提高设备的有效性和易用性。然而，人工智慧和机器人等技术的进步为改善神经復健效果提供了巨大的机会。但是，将这些创新成果整合到临床实践中需要进行深入的研究并获得监管部门的核准。儘管高昂的成本和严格的报销政策构成挑战，但扩大神经復健服务覆盖范围的前景仍然光明。

神经復健设备市场驱动因素

神经復健设备市场主要由持续的技术创新所驱动。机器人、虚拟实境、穿戴式感测器和脑机介面等领域的创新正推动着更先进、更有效的神经復健工具的研发。这些最尖端科技能够实现更个人化的治疗和復健体验。例如，先进的机器人外骨骼旨在帮助行动不便者改善行走和运动技能。持续的技术进步正在推动创新解决方案的开发，这些方案有望显着改善患者的康復过程。

神经復健设备市场的限制因素

神经復健设备市场面临的主要限制因素是这些技术相关的高成本。诸如机器人技术和脑机介面最尖端科技往往会推高设备价格。此外，操作这些先进设备所需的专业知识也会增加整体治疗成本。因此，这种经济障碍可能会限制神经復健设备的普及，尤其是在医疗资源有限或保险覆盖不足的地区。这些经济挑战可能会阻碍这些关键復健方案的广泛应用，进而影响真正需要的患者。

神经復健设备市场趋势

神经復健设备市场正呈现出向远距復健解决方案融合的显着趋势。这种创新方法使患者能够远端参与復健治疗，并利用先进技术与医疗专业人员进行即时互动。远距復健提高了便利性和可及性，使患者能够在舒适的家中参与治疗。它还有助于持续监测和个人化护理，从而改善治疗效果。这种转变不仅解决了传统面对面復健的难题，而且鼓励更多患者获得所需的治疗，从而推动了神经復健设备在医疗保健生态系统中的成长和普及。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Medtronic（US）
Abbott Laboratories（US）
Boston Scientific Corporation（US）
Stryker Corporation（US）
Smith & Nephew plc（UK）
Ekso Bionics Holdings, Inc.（US）
Bioxtreme Robotics Rehabilitation（Italy）
ReWalk Robotics Ltd.（Israel）
Neurostyle Pte. Ltd.（Singapore）
Kinova Robotics（Canada）
Neuro Rehab VR（US）
Tyromotion GmbH（Austria）
Neofect（South Korea）
Enraf-Nonius（Netherlands）
Hobbs Rehabilitation（UK）
Motek Medical BV（Netherlands）

结论与建议

简介目录

Product Code: SQMIG35A2377

Neurorehabilitation Devices Market size was valued at USD 1.73 Billion in 2024 and is poised to grow from USD 1.88 Billion in 2025 to USD 3.58 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The neurorehabilitation devices market is evolving in response to the increasing demand for effective interventions for neurological conditions like stroke, multiple sclerosis, and Parkinson's disease, driven by rising prevalence due to an aging population and lifestyle changes. This demand highlights the necessity for innovative solutions that facilitate recovery and improved functional abilities, offering patients personalized therapies to regain independence. While the market faces challenges, including the need for ongoing research to enhance device effectiveness and usability, technological advancements like artificial intelligence and robotics provide significant opportunities for improving neurorehabilitation outcomes. However, integrating these innovations into clinical practice requires thorough research and regulatory approval. Despite high costs and limited reimbursement policies posing challenges, opportunities for expanding accessibility to neurorehabilitation services remain promising.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurorehabilitation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurorehabilitation Devices Market Segments Analysis

Global Neurorehabilitation Devices Market is segmented by Type, Application, End User and region. Based on Type, the market is segmented into Neuro-Robotic Devices, Non-Invasive Stimulators and Brain-Computer Interfaces. Based on Application, the market is segmented into Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy and Others. Based on End User, the market is segmented into Rehabilitation Centers, Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurorehabilitation Devices Market

The neurorehabilitation devices market is significantly driven by ongoing technological advancements. Innovations in fields such as robotics, virtual reality, wearable sensors, and brain-computer interfaces have led to the creation of more advanced and effective neurorehabilitation tools. These cutting-edge developments facilitate the delivery of tailored therapies and personalized rehabilitation experiences for patients. For instance, sophisticated robotic exoskeletons are designed to aid individuals with mobility challenges, enhancing their ability to walk and improving motor skills. As technology continues to evolve, it fosters the development of innovative solutions that hold great promise for enhancing the rehabilitation journey of patients.

Restraints in the Neurorehabilitation Devices Market

A significant limitation in the neurorehabilitation devices market is the substantial expense linked to these technologies. Cutting-edge innovations, including robotics and brain-computer interfaces, often drive up the price of these devices. Furthermore, the need for specialized knowledge to operate these advanced tools can add to the overall treatment costs. As a result, this financial barrier may restrict access to neurorehabilitation devices, especially in areas where healthcare resources are scarce or insurance coverage is insufficient. Such economic challenges can impede the widespread adoption and use of these crucial rehabilitation solutions for patients in need.

Market Trends of the Neurorehabilitation Devices Market

The neurorehabilitation devices market is witnessing a significant trend towards the integration of tele-rehabilitation solutions. This innovative approach enables patients to engage in rehabilitation remotely, leveraging advanced technologies to facilitate real-time interactions with healthcare professionals. Tele-rehabilitation enhances convenience and accessibility, allowing patients to participate in therapy sessions from the comfort of their homes. Moreover, it fosters continuous monitoring and personalized care, improving treatment outcomes. This shift not only addresses the challenges posed by traditional in-person rehabilitation but also encourages more patients to pursue necessary therapy, thus driving the growth and adoption of neurorehabilitation devices in the healthcare ecosystem.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global Neurorehabilitation Devices Market Size by Type & CAGR (2026-2033)

Market Overview
Neuro-Robotic Devices
Non-Invasive Stimulators
Brain-Computer Interfaces

Global Neurorehabilitation Devices Market Size by Application & CAGR (2026-2033)

Market Overview
Brain Stroke
Parkinson's Disease
Multiple Sclerosis
Spinal Cord Injury
Traumatic Brain Injury
Cerebral Palsy
Others

Global Neurorehabilitation Devices Market Size by End User & CAGR (2026-2033)

Market Overview
Rehabilitation Centers
Hospitals
Clinics

Global Neurorehabilitation Devices Market Size & CAGR (2026-2033)

North America (Type, Application, End User)
- US
- Canada
Europe (Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ekso Bionics Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioxtreme Robotics Rehabilitation (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ReWalk Robotics Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neurostyle Pte. Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kinova Robotics (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuro Rehab VR (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tyromotion GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neofect (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enraf-Nonius (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hobbs Rehabilitation (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Motek Medical B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments